Loading...
Future Returns Will Depend On JAK2 Program Validation And Incyte Milestones
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
06 Mar 26
Views
18
06 Mar
US$5.33
AnalystLowTarget's Fair Value
US$3.00
77.7% overvalued intrinsic discount1Y
566.3%7D
21.7%1Y
566.3%7D
21.7%Author's Valuation
US$377.7% overvalued intrinsic discount
AnalystLowTarget Fair Value